Learn More
Cayman Chemical dI-coupled CBDP 1mg

Supplier: Cayman Chemical 413231 MG

An SGLT1 and SGLT2 inhibitor (IC50s 22.8 and 2.3 UM respectively) dietary administration reduces blood glucose and HbA1c levels in a rat model of streptozotocin-induced diabetes at 0.01 w/w suppresses the development of hyperglycemia and hypertriglyceridemia and reduces HbA1c levels in the KKAY mouse model of type 2 diabetes exacerbates post-infarction cardiac dysfunction in a rat model of left anterior descending coronary artery ligation-induced myocardial infarction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.